» Articles » PMID: 8187980

Myf5, MyoD, Myogenin and MRF4 Myogenic Derivatives of the Embryonic Mesenchymal Cell Line C3H10T1/2 Exhibit the Same Adult Muscle Phenotype

Overview
Journal Differentiation
Publisher Elsevier
Date 1994 Feb 1
PMID 8187980
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Cells of the embryonic mesenchymal cell line C3H10T1/2 have revealed the potential that the four regulatory factors belonging to the MyoD family have to activate myogenesis. In the present study we have further investigated the myogenic phenotype of C3H10T1/2 cells stably transfected with either Myf5, MyoD, myogenin or MRF4 cDNAs. We have studied the influence of each transfected cDNA on expression of the four endogenous muscle regulatory genes and on the ability of these embryonic myogenic derivatives to express adult muscle genes. No trace of endogenous transcripts distinct from the exogenous one was found in any of the four converted populations at the myoblast stage. This indicates that cross-activation within the MyoD family does not occur at the myoblast stage in these cells. Similarly, evidence was obtained that auto- or cross-activation of the Myf5 gene occurs neither at the myoblast stage nor at the myotube stage and that no autoactivation of the MRF4 gene occurs. Our results together with previous observations indicate that in C3H10T1/2 myogenic derivatives: (1) Autoactivation at the myoblast stage is restricted to MyoD (2) Expression from each cDNA alone is sufficient to establish and maintain the myoblast phenotype (3) The endogenous Myf5 gene is not mobilized. We have also observed that endogenous transcripts for MyoD and myogenin begin to accumulate at the onset of differentiation in the four myogenic derivatives, whereas accumulation of endogenous MRF4 transcripts starts after myotubes have formed and occurs at a much lower level (100- to 500-fold lower) than in differentiated cultures of myosatellite cells.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Crosstalk among canonical Wnt and Hippo pathway members in skeletal muscle and at the neuromuscular junction.

Hashemolhosseini S, Gessler L Neural Regen Res. 2024; 20(9):2464-2479.

PMID: 39248171 PMC: 11801303. DOI: 10.4103/NRR.NRR-D-24-00417.


Unraveling signatures of chicken genetic diversity and divergent selection in breed-specific patterns of early myogenesis, nitric oxide metabolism and post-hatch growth.

Kochish I, Titov V, Nikonov I, Brazhnik E, Vorobyov N, Korenyuga M Front Genet. 2023; 13:1092242.

PMID: 36712856 PMC: 9874007. DOI: 10.3389/fgene.2022.1092242.


Protein 4.1R Influences Myogenin Protein Stability and Skeletal Muscle Differentiation.

Huang S, Zhou A, Nguyen D, Zhang H, Benz Jr E J Biol Chem. 2016; 291(49):25591-25607.

PMID: 27780863 PMC: 5207257. DOI: 10.1074/jbc.M116.761296.


Reduced Notch signalling leads to postnatal skeletal muscle hypertrophy in Pofut1cax/cax mice.

Al Jaam B, Heu K, Pennarubia F, Segelle A, Magnol L, Germot A Open Biol. 2016; 6(9).

PMID: 27628322 PMC: 5043585. DOI: 10.1098/rsob.160211.


The fusion protein SS18-SSX1 employs core Wnt pathway transcription factors to induce a partial Wnt signature in synovial sarcoma.

Cironi L, Petricevic T, Fernandes Vieira V, Provero P, Fusco C, Cornaz S Sci Rep. 2016; 6:22113.

PMID: 26905812 PMC: 4764983. DOI: 10.1038/srep22113.